Anna Protopapas
2017
In 2017, Anna Protopapas earned a total compensation of $916.5K as Chief Executive Officer and President at Mersana Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $189,265 |
|---|---|
| Option Awards | $291,120 |
| Salary | $430,148 |
| Other | $6,000 |
| Total | $916,533 |
Protopapas received $430.1K in salary, accounting for 47% of the total pay in 2017.
Protopapas also received $189.3K in non-equity incentive plan, $291.1K in option awards and $6K in other compensation.
Rankings
In 2017, Anna Protopapas' compensation ranked 9,389th out of 14,666 executives tracked by ExecPay. In other words, Protopapas earned more than 36.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,389 out of 14,666 | 36th |
Division Manufacturing | 3,611 out of 5,772 | 37th |
Major group Chemicals And Allied Products | 1,243 out of 2,075 | 40th |
Industry group Drugs | 999 out of 1,731 | 42nd |
Industry Pharmaceutical Preparations | 785 out of 1,333 | 41st |
Source: SEC filing on April 30, 2018.
Protopapas' colleagues
We found two more compensation records of executives who worked with Anna Protopapas at Mersana Therapeutics in 2017.
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020
Mersana Therapeutics CEO Anna Protopapas' 2018 pay jumps 184% to $2.6M
April 23, 2019